Inhibition of Breast Cancer Cell Growth by Combined Treatment with Vitamin D3 Analogues and Tamoxifen

Cancer Research

Volumn 54, Issue 21, 1994, Pages 5711-5717

  Vink van Wijngaarden, Trudy ^a   Pols, Huibert A P ^a   Buurman, Cok J ^a   van den Bemd, Gert Jan C M ^a   Dorssers, Lambert C J ^a   Birkenhäger, Jan C ^a   van Leeuwen, Johannes P T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CB 966; COLECALCIFEROL; ESTROGEN RECEPTOR; LEXACALCITOL; SEOCALCITOL; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; DRUG POTENTIATION; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CALCITRIOL; CELL DIVISION; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; ESTRADIOL; HUMAN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, CALCITRIOL; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0027988168     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reichel, H. Koeffler, H.P. and Norman, A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320: 980-991, 1989.
2. Walters, M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13: 719-764, 1992.
3. Frampton, R.J. Omond, S.A. and Eisman, J.A. Inhibition of human cancer cell growth by 1, 25-dihydroxyvitamin D3 metabolites. Cancer Res. 43: 4443-4447, 1983.
4. Chouvet, C. Vicard, E. Devonec, M. and Saez, S. 1, 25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J. Steroid Biochem. 24: 373-376, 1986.
5. lino, Y. Yoshida, M. Sugamata, N. Maemura, M. Ohwada, S. Yokoe, T. Ishikita, T. Horiuchi, R. and Morishita, Y. 1α-Hydroxyvitamin D3, hypercalcemia, and growth suppression of 7, 12-dimethylbenz[a] anthracene-induced rat mammary tumors. Breast Cancer Res. Treat. 22: 133-140, 1992.
6. Pols, H.A.P. Birkenhäger, J.C. Foekens, J.A. and Van Leeuwen, J.P.T.M. Vitamin D: a modulator of cell proliferation and differentiation. J. Steroid Biochem. Mol. Biol. 6: 873-876, 1990.
7. Abe, J. Morikawa, M. Miyamoto, K. Kaiho, S. Fukushima, M. Miyaura, C. Abe, E. Suda, T. and Nishii, Y. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. FEBS Lett. 226: 58-62, 1987.
8. Binderup, L. Latini, S. Binderup, E. Bretting, C. Calverley, M. and Hansen, K. 20-Epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 42: 1569-1575, 1991.
9. Binderup, E. Calverley, M.J. and Binderup, L. Synthesis and biological activity of lα-hydroxylated vitamin D analogues with polyunsaturated side chains. In: A.W. Norman, R. Bouillon, and M. Thomasset (eds.), Vitamin D. Gene regulation, Structure-Function Analysis and Clinical Application, pp. 192-193. Berlin, Germany: Walter de Gruyter, 1991.
10. Sato, K. Nishii, Y. Woodiel, F.N. and Raisz, L.G. Effects of two new vitamin D3 derivatives, 22-oxa-1 α-25-dihydroxyvitamin D3 (OCT) and 20-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture. Bone, 14: 47-51, 1993.
11. Abe, J. Nakano, T. Nishii, Y. Matsumoto, T. Ogata, E. and Ikeda, K. A novel vitamin D3 analog, 22-oxa-1, 25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology, 129: 832-837, 1991.
12. Colston, K.W. Mackay, A.G. James, S.Y. and Binderup, L. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44: 2273-2280, 1992.
13. Mathiasen, I.S. Colston, K.W. Binderup, L. EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Mol. Biol. 46: 365-371, 1993.
14. Eisman, J.A. Suva, L.J. Sher, E. Pearce, P.J. Funder, J.W. and Martin, T.J. Frequency of 1, 25-dihydroxyvitamin D3 receptor in human breast cancer. Cancer Res. 41: 5121-5124, 1981.
15. Berger, U. Wilson, P. McClelland, R.A. Colston, K. Haussler, M.R. Pike, J.W. and Coombes, R.C. Immunocytochemical detection of 1, 25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Res. 47: 6793-6799, 1987.
16. Jordan, V.C. A current view of tamoxifen for the treatment and prevention of breast cancer. Br. J. Pharmacol. 110: 507-517, 1993.
17. Jordan, V.C. Robinson, S.P. and Welshons, W.V. Resistance to antiestrogen therapy. In: D. Kessel (ed.), Resistance to Antineoplastic Drugs, pp. 403-427. Boca Raton: CRC Press, 1989.
18. Vink-van Wijngaarden, T. Pols, H.A.P. Buurman, C.J. Birkenhäger, J.C. and Van Leeuwen, J.P.T.M. Combined effects of 1, 25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat. 29: 161-168, 1993.
19. Dorssers, L.C.J. Van Agthoven, T. Dekker, A. Van Agthoven, T.L.A. and Kok, E.M. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site. Mol. Endocrinol. 7: 870-878, 1993.
20. Van Agthoven, T. Van Agthoven, T.L.A. Portengen, H. Foekens, J.A. and Dorssers, L.C.J. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res. 52: 5082-5088, 1992.
21. Westergren-Thorsson, G. Önnervik, P.O. Fransson, L.I., and Malmström, A. Proliferation of cultured fibroblasts is inhibited by L-induronate-containing glyco-saminoglycans. J. Cell. Physiol. 147: 523-530, 1991.
22. Chomczifiski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
23. Davis, L.G. Dibner, M.D. and Battey, J.F. Formaldehyde gel for electrophoretic separation of RNA and Northern blot. In: Basic Methods in Molecular Biology, pp. 143-149. Amsterdam, the Netherlands: Elsevier, 1986.
24. Dalla-Favera, R. Gelmann, E.P. Martinotti, S. Franchini, G. Papas, T.S. Gallo, R.C. and Wong-Staal, F. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc. Natl. Acad. Sci. USA, 79: 6497-6501, 1982.
25. Benham, F.J. Hodgkinson, S. and Davies, K.E. A glyceraldehyde-3-phosphate dehydrogenase pseudogene on the short arm of the human X chromosome defines a multigene family. EMBO J. 3: 2635-2640, 1984.
26. Pols, H.A.P. Birkenhäger, J.C. Schilte, J.P. Bos, M.P. and Van Leeuwen, J.P.T.M. The effects of MC903 on 1, 25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption. Bone Miner. 14: 103-111, 1991.
27. Pols, H.A.P. Birkenhäger, J.C. and Van Leeuwen, J.P.T.M. Vitamin D analogues: from molecule to clinical application. Clin. Endocrinol. 40: 285-291, 1994.
28. Abe, J. Nakamura, K. Takita, Y. Nakano, T. Irie, H. and Nishii, Y. Prevention of immunological disorders in MRL/I mice by a new synthetic analogue of vitamin D3: 22-oxa-1 α,25-dihydroxyvitamin D3. J. Nutr. Sci. Vitaminol. 36: 21-31, 1990.
29. Orr, F.W. Kostenuik, P. Sanchez-Sweatman, O.H. and Singh, G. Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res. Treat. 25: 151-163, 1993.
30. Abe-Hashimoto, J. Kikuchi, T. Matsumoto, T. Nishii, Y. Ogata, E. and Ikeda, K. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res. 53: 2534-2537, 1993.
31. Osborne, C.K. Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin. Oncol. 12: 317-326, 1985.
32. Wright, C.D.P. Garrahan, N.J. Stanton, M. Gazet, J.C. Mansell, R.E. Compston, J.E. Effect of long-term tamoxifen therapy on cancellous bone remodeling and structure in women with breast cancer. J. Bone Miner. Res. 9: 153-159, 1994.
33. Shiu, R.P.C. Watson, P.H. and Dubik, D. c-Myc oncogene expression in estrogen-dependent and -independent breast cancer. Clin. Chem. 39: 353-355, 1993.
34. Freiss, G. Prebois, C. Rochefort, H. and Vignon, F. Anti-steroidal and anti-growth factor activities of anti-estrogens. J. Steroid Biochem. Mol. Biol. 37: 777-781, 1990.
35. Reitsma, P.H. Rothberg, P.G. Astrin, S.M. Trial, J. Bar-Shavit, Z. Hall, A. Teitelbaum, S.L. and Kahn, A.J. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (Lond.), 306: 492-494, 1983.
36. Matsumoto, K. Hashimoto, K. Nishida, Y. Hashiro, M. and Yoshikawa, K. Growth-inhibitory effects of 1, 25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem. Biophys. Res. Commun. 166: 916-923, 1990.
37. Kremer, R. Bolivar, I. Goltzman, D. and Hendy, G.N. Influence of calcium and 1, 25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology, 125: 935-941, 1989.
38. Eisman, J.A. Barkla, D.H. and Tutton, P.J.M. Suppression of in vivo growth of human cancer solid tumor xenografts by 1, 25-dihydroxyvitamin D3. Cancer Res. 47: 21-25, 1987.